Anthony Tantuccio

In his current role, Anthony leads efforts to advance continuous tableting technology by identifying opportunities for scientific innovation and enhancing manufacturing capabilities. Anthony is dedicated to addressing and overcoming challenges that hinder the widespread adoption of continuous tableting, ensuring robust and effective implementation of new solutions. Prior to joining Hovione, he held technical positions at Merck & Co. and Bristol Myers Squibb, where he contributed to the CMC development and commercialization of oral solid dosage products. His experience includes proof of concept, technical development, and the deployment of continuous manufacturing systems.